Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Large Blend · Federated Hermes

Federated Hermes SDG Engagement Equity Fund Institutional Shares (FHESX)

Ticker FHESX · Since 2018-11-06 · · Holdings as of Jul 31, 2026

Expense ratio
0.94%$94/yr per $10k
5-yr return
+4.6%annualized
1-yr return
+2.0%as of Dec 2024
Net assets
$18.4Mall share classes
Holdings
58

Bottom line

Is FHESX a good fund? The bottom line

FHESX is the Institutional share class of Federated Hermes SDG Engagement Equity Fund, an actively managed large blend mutual fund from Federated Hermes.

Annual fees run 0.94% — about $94 a year on every $10,000 invested, more expensive than 59% of large blend funds we track.

It returned +2.0% over one year, +4.6% a year over five years (as of Dec 31, 2024, per its prospectus).

With $18.4 million in net assets and 58 holdings, its largest position is West Pharmaceutical Services Inc (3.0%) and the top 10 make up 25.9% of the portfolio.

What stands out

  • No front-end sales load

What to watch

  • 5-year return in the bottom quarter of its category
  • Small fund ($18.4 million) — small funds are likelier to close

Updated Nov 19, 2026

What FHESX invests in

The Funds investment objective is to provide long-term capital appreciation alongside positive societal impact. The objective may be changed by the Funds Board of Trustees (the Trustees) without shareholder approval.

The Fund pursues its investment objective of long-term capital appreciation alongside positive societal impact by investing, under normal circumstances, at least 80% of its net assets in equity securities. In seeking to achieve its objective, the Fund may invest its assets in companies of all capitalizations; however, the Funds investment adviser or sub-adviser (as applicable, the Adviser) anticipates that the Fund will be primarily invested in equity securities and equity-related securities (such as depositary receipts) of small- and mid-capitalization companies in both the United States and foreign markets (including emerging markets). The Fund may also invest in and gain exposure to securities of other investment companies, real estate investment trusts (REITs), and money market funds including funds advised by the Adviser or its affiliates. In managing the assets of the Fund, the…

From the fund's prospectus (filed Dec 29, 2025).

FHESX performance

Fund calendar-year total returns, 2019–2024 2019: +25.4%; 2020: +8.3%; 2021: +17.5%; 2022: −18.5%; 2023: +18.3%; 2024: +2.0% +25.4% 2019 +8.3% 2020 +17.5% 2021 −18.5% 2022 +18.3% 2023 +2.0% 2024
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
FHESX+2.0%+4.6%—
Large Blend median+13.8%+9.7%+10.9%

Source: Fund prospectus, as of Dec 31, 2024

Full FHESX performance history →

What FHESX costs

On a $10,000 investment, FHESX's 0.94% expense ratio costs about $94 a year. The prospectus estimates $1,534 in total costs over 10 years (assuming 5% annual returns). The median large blend fund charges 0.83%.

See the full FHESX fee table →

FHESX top 10 holdings

#Holding% of fund
1West Pharmaceutical Services Inc WST3.04%
2Wintrust Financial Corp WTFC3.00%
3Steris Plc STE2.63%
4Credicorp Ltd BAP2.62%
5Viscofan Industria Navarra De Envoltura Celulosicas Sa VIS2.58%
6Crane Company CR2.51%
7Aptargroup Inc ATR2.48%
8Reinsurance Group Of America Inc RGA2.46%
9Ansell Ltd ANN2.35%
10Horiba Ltd 68562.24%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 25.9% of the fund. See all top 25 holdings and asset mix →

Alternatives to FHESX

More funds like FHESX →

FHESX FAQ

What is the expense ratio of FHESX?
FHESX's expense ratio is 0.94%, which works out to about $94 a year for every $10,000 invested. The prospectus estimates total costs of $1,534 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is FHESX a good investment?
It depends on your goals, but the data points to: no front-end sales load; 5-year return in the bottom quarter of its category; small fund ($18.4 million) — small funds are likelier to close. This is general information, not personalized advice.
What does FHESX hold?
FHESX's largest holdings are West Pharmaceutical Services Inc (3.0%), Wintrust Financial Corp (3.0%), Steris Plc (2.6%), Credicorp Ltd (2.6%), Viscofan Industria Navarra De Envoltura Celulosicas Sa (2.6%). It holds 58 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
What is FHESX's 5-year return?
FHESX returned +4.6% a year over the five years ending Dec 31, 2024. Past performance does not guarantee future results.
Does FHESX have a sales load?
No. FHESX has no front-end sales charge.
Who manages FHESX?
FHESX is offered by Federated Hermes through Federated Hermes Adviser Series.